# Pathophysiology and Prevention of Perioperative Myocardial Injury: A Prospective Randomized Controlled Trial

Study · id `cardio:ct-nct01810796` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01810796](<https://clinicaltrials.gov/study/NCT01810796>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01810796

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

## Technical summary

Registry record NCT01810796. Randomized; quadruple masking; primary purpose prevention. Start 2013-12 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT01810796, source copy `cardio:ctgov-nct01810796-2013-03-14`, retrieved 2026-10-26)
- Start date: 2013-12 (registry gives no type) (ClinicalTrials.gov record NCT01810796, source copy `cardio:ctgov-nct01810796-2013-03-14`, retrieved 2026-10-26)
- Primary completion: 2016-12 (anticipated) (ClinicalTrials.gov record NCT01810796, source copy `cardio:ctgov-nct01810796-2013-03-14`, retrieved 2026-10-26)
- Completion: 2017-12 (anticipated) (ClinicalTrials.gov record NCT01810796, source copy `cardio:ctgov-nct01810796-2013-03-14`, retrieved 2026-10-26)
- Countries: Israel (ClinicalTrials.gov record NCT01810796, source copy `cardio:ctgov-nct01810796-2013-03-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01810796-2013-03-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pathophysiology and Prevention of Perioperative Myocardial Injury: A Prospective Randomized Controlled Trial
- Condition: Coronary Artery Disease,
- Intervention (Drug): Ranolazine
- Lead sponsor: Hadassah Medical Organization
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Hadassah Medical Organization (`cardio:org-hadassah-medical-organization`)

## Provenance

Content hash: 0f74cf1fbff0a16908cd9a999e5ca379885aa9bff26faf58eb76cf2383218db3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
